207 related articles for article (PubMed ID: 19160319)
1. First line chemotherapy in low risk gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Hancock BW; Osborne R
Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
[TBL] [Abstract][Full Text] [Related]
2. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Hancock BW; Osborne R; Lawrie TA
Cochrane Database Syst Rev; 2012 Jul; 7(7):CD007102. PubMed ID: 22786502
[TBL] [Abstract][Full Text] [Related]
3. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Lawrie TA; Alazzam M; Tidy J; Hancock BW; Osborne R
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007102. PubMed ID: 27281496
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
Deng L; Zhang J; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD005196. PubMed ID: 23440800
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
[TBL] [Abstract][Full Text] [Related]
8. Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?
Miller CR; Chappell NP; Sledge C; Leath CA; Phippen NT; Havrilesky LJ; Barnett JC
Gynecol Oncol; 2017 Jan; 144(1):125-129. PubMed ID: 27816248
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of first-line single-agent chemotherapy regimens in low-risk gestational trophoblastic neoplasia: A network meta-analysis.
Li J; Li S; Yu H; Wang J; Xu C; Lu X
Gynecol Oncol; 2018 Feb; 148(2):247-253. PubMed ID: 29203174
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
[TBL] [Abstract][Full Text] [Related]
11. Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women.
Uberti EM; Fajardo Mdo C; da Cunha AG; Frota SS; Braga A; Ayub AC
Rev Bras Ginecol Obstet; 2015 Jun; 37(6):258-65. PubMed ID: 26200823
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for high-risk gestational trophoblastic tumour.
Xue Y; Zhang J; Wu TX; An RF
Cochrane Database Syst Rev; 2006 Jul; (3):CD005196. PubMed ID: 16856085
[TBL] [Abstract][Full Text] [Related]
13. A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.
Shah NT; Barroilhet L; Berkowitz RS; Goldstein DP; Horowitz N
J Reprod Med; 2012; 57(5-6):211-8. PubMed ID: 22696815
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for high-risk gestational trophoblastic tumour.
Deng L; Yan X; Zhang J; Wu T
Cochrane Database Syst Rev; 2009 Apr; (2):CD005196. PubMed ID: 19370618
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
Osborne RJ; Filiaci V; Schink JC; Mannel RS; Alvarez Secord A; Kelley JL; Provencher D; Scott Miller D; Covens AL; Lage JM
J Clin Oncol; 2011 Mar; 29(7):825-31. PubMed ID: 21263100
[TBL] [Abstract][Full Text] [Related]
16. Low-Risk Gestational Trophoblastic Neoplasia in Manitoba: Experience With Alternating Methotrexate and Dactinomycin.
Carlson V; Walters L; Lambert P; Dean E; Lotocki R; Altman AD
Int J Gynecol Cancer; 2018 Oct; 28(8):1448-1452. PubMed ID: 30095710
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia.
Maestá I; Nitecki R; Desmarais CCF; Horowitz NS; Goldstein DP; Elias KM; Berkowitz RS
Gynecol Oncol; 2020 May; 157(2):372-378. PubMed ID: 32037196
[TBL] [Abstract][Full Text] [Related]
19. Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?
Poli JG; Paiva G; Freitas F; Mora P; Velarde LGC; Junior JA; Filho JR; Elias KM; Horowitz NS; Braga A; Berkowitz RS
Gynecol Oncol; 2021 Sep; 162(3):638-644. PubMed ID: 34266689
[TBL] [Abstract][Full Text] [Related]
20. Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease.
Lee YJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Mar; 28(2):e8. PubMed ID: 27819410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
